Ballentine Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $832K | Buy |
|
|||||
|
2025
Q2 | $688K | Buy |
|
|||||
|
2025
Q1 | $523K | Buy |
|
|||||
|
2024
Q4 | $373K | Buy |
|
|||||
|
2024
Q3 | $296K | Sell |
|
|||||
|
2024
Q2 | $773K | Buy |
|
|||||
|
2024
Q1 | $359K | Buy |
|
|||||
|
2023
Q4 | $427K | Buy |
|
|||||
|
2023
Q3 | $393K | Buy |
|
|||||
|
2023
Q2 | $422K | Buy |
|
|||||
|
2023
Q1 | $395K | Sell |
|
|||||
|
2022
Q4 | $410K | Sell |
|
|||||
|
2022
Q3 | $395K | Buy |
|
|||||
|
2022
Q2 | $241K | Sell |
|
|||||
|
2022
Q1 | $263K | Sell |
|
|||||
|
2021
Q4 | $317K | Buy |
|
|||||
|
2021
Q3 | $326K | Sell |
|
|||||
|
2021
Q2 | $454K | Sell |
|
|||||
|
2021
Q1 | $395K | Sell |
|
|||||
|
2020
Q4 | $355K | Sell |
|
|||||
|
2020
Q3 | $1.5M | Sell |
|
|||||
|
2020
Q2 | $1.85M | Sell |
|
|||||
|
2020
Q1 | $2.21M | Buy |
|
|||||
|
2019
Q4 | $2.06M | Buy |
|
|||||
|
2019
Q3 | $468K | Buy |
|
|||||
|
2019
Q2 | $460K | Buy |
|
|||||
|
2019
Q1 | $459K | Sell |
|
|||||
|
2018
Q4 | $587K | Sell |
|
|||||
|
2018
Q3 | $787K | Sell |
|
|||||
|
2018
Q2 | $1.19M | Buy |
|
|||||
|
2018
Q1 | $1.11M | Buy |
|
|||||
|
2017
Q4 | $598K | Buy |
|
|||||
|
2017
Q3 | $525K | Sell |
|
|||||
|
2017
Q2 | $480K | Buy |
|
|||||
|
2017
Q1 | $364K | Sell |
|
|||||
|
2016
Q4 | $495K | Sell |
|
|||||
|
2016
Q3 | $599K | Sell |
|
|||||
|
2016
Q2 | $476K | Buy |
|
|||||
|
2016
Q1 | $472K | Buy |
|
|||||
|
2015
Q4 | $400K | Sell |
|
|||||
|
2015
Q3 | $412K | Buy |
|
|||||
|
2015
Q2 | $485K | Buy |
|
|||||
|
2015
Q1 | $488K | Sell |
|
|||||
|
2014
Q4 | $396K | Sell |
|
|||||
|
2014
Q3 | $429K | Buy |
|
|||||
|
2014
Q2 | $374K | Sell |
|
|||||
|
2014
Q1 | $375K | Buy |
|
|||||
|
2013
Q4 | $327K | Buy |
|
|||||
|
2013
Q3 | $262K | Buy |
|